Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature

Immune checkpoint inhibitor (ICI) is an up-to-date therapy for cancer with a promising efficacy, but it may cause unique immune-related adverse events (irAEs). Although irAEs could affect any organ, irAEs-induced whole urinary tract expansion was rarely reported. Herein, we reported a 27-year-old ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qihao, Qin, Zhiquan, Yan, Peiyuan, Wang, Qunjiang, Qu, Jing, Chen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587548/
https://www.ncbi.nlm.nih.gov/pubmed/37869004
http://dx.doi.org/10.3389/fimmu.2023.1226993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587548/
https://www.ncbi.nlm.nih.gov/pubmed/37869004
http://dx.doi.org/10.3389/fimmu.2023.1226993

Ejemplares similares